Radioligand Therapy

At Genesis Cancer and Blood Institute, we specialize in providing innovative treatment options and personalized care for cancer patients. Radioligand, or RLT, therapeutics is a cutting-edge approach to cancer treatment that targets tumors with precision radiopharmaceuticals. Unlike traditional chemotherapy or radiation therapy, which can harm healthy cells along with cancerous ones, RLT therapy delivers radiation directly to cancer cells, reducing exposure to healthy tissue and minimizing side effects.

Our experienced oncologists will work closely with you to determine if RLT therapy is the right option for your specific type and stage of cancer. We understand that each patient is unique, and we tailor our treatment plans to meet your individual needs and preferences.

Benefits of Radioligand Therapeutics

  • Precision Targeting: Depending on the cancer type, radioligand therapy specifically targets cancer cells, leading to more effective treatment and fewer side effects.
  • Minimal Impact on Healthy Tissue: Healthy tissues surrounding the tumor are far less likely to be damaged from RLT exposure, reducing the risk of long-term complications.
  • Personalized Approach: Our team will create a customized treatment plan based on your medical history, tumor characteristics, and treatment goals.
  • Potential for Improved Outcomes: Radioligand therapy has shown promising results in shrinking tumors, managing symptoms, and extending survival for many cancer patients.

Radioligand therapy may not be suitable for all cancer patients. Talk to your physician to determine the most appropriate treatment options.